nalidixic acid has been researched along with Cholera in 10 studies
Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We identified a poor clinical response to treatment of cholera with a single 1 g dose of ciprofloxacin, a standard treatment for cholera." | 7.81 | Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1. ( Ahmed, S; Bennish, ML; Khan, WA; Saha, D; Salam, MA, 2015) |
| " cholera were as follows 76% [67,84] to furazolidone, 65% [29,94] to nitrofurantoin, 55% [44,66] to nalidixic acid, 10% [2,23] to rifampicin, 4%(0, 12) to novobiocin, 4% [2,6] to norfloxacin, 3% [1,4] to ciprofloxacin, 1%(0, 3) to sparofloxacin, 0%(0, 3) to levofloxacin, 0%(0, 2) to ofloxacin, 0%(0, 0) to gatifloxacin." | 5.22 | Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis. ( Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA, 2022) |
| "We identified a poor clinical response to treatment of cholera with a single 1 g dose of ciprofloxacin, a standard treatment for cholera." | 3.81 | Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1. ( Ahmed, S; Bennish, ML; Khan, WA; Saha, D; Salam, MA, 2015) |
| "Cholera can be treated with nalidixic acid or chloramphenical in young children while doxycycline for older children." | 3.71 | Drug sensitivity pattern of cholera in children. ( Memon, IA; Murtaza, G, 2002) |
| "Although cholera is an endemic disease in Bangladesh, India and other countries, it was never a significant cause of gastroenteritis in Pakistan before 1988." | 1.30 | Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital. ( Farooqui, BJ; Nizami, SQ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rostami, A | 1 |
| Zadeh, FA | 1 |
| Ebrahimzadeh, F | 1 |
| Jafari-Sales, A | 1 |
| Gholami, S | 1 |
| Shah, MM | 1 |
| Bundi, M | 1 |
| Kathiiko, C | 1 |
| Guyo, S | 1 |
| Galata, A | 1 |
| Miringu, G | 1 |
| Ichinose, Y | 1 |
| Yoshida, LM | 1 |
| Mohan, B | 1 |
| Sethuraman, N | 1 |
| Verma, R | 1 |
| Taneja, N | 2 |
| Khan, WA | 1 |
| Saha, D | 1 |
| Ahmed, S | 1 |
| Salam, MA | 1 |
| Bennish, ML | 1 |
| Kingston, JJ | 1 |
| Zachariah, K | 1 |
| Tuteja, U | 1 |
| Kumar, S | 1 |
| Batra, HV | 1 |
| Memon, IA | 1 |
| Murtaza, G | 1 |
| Biswal, M | 1 |
| Tarai, B | 1 |
| Sharma, M | 1 |
| Faruque, SM | 1 |
| Biswas, K | 1 |
| Udden, SM | 1 |
| Ahmad, QS | 1 |
| Sack, DA | 1 |
| Nair, GB | 1 |
| Mekalanos, JJ | 1 |
| Nizami, SQ | 1 |
| Farooqui, BJ | 1 |
| Ryzhko, IV | 1 |
| Tsuraeva, RI | 1 |
| Lomov, IuM | 1 |
| Shut'ko, AG | 1 |
| Mishan'kin, BN | 1 |
| Koroleva, NS | 1 |
| Samokhodkina, ED | 1 |
| Shcherbaniuk, AI | 1 |
1 review available for nalidixic acid and Cholera
| Article | Year |
|---|---|
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacteria | 2022 |
9 other studies available for nalidixic acid and Cholera
| Article | Year |
|---|---|
Antibiotic-Resistant Vibrio cholerae O1 and Its SXT Elements Associated with Two Cholera Epidemics in Kenya in 2007 to 2010 and 2015 to 2016.
Topics: Anti-Bacterial Agents; Cholera; Disease Outbreaks; Epidemics; Humans; Kenya; Nalidixic Acid; Vibrio | 2023 |
Speciation, clinical profile & antibiotic resistance in
Topics: Adolescent; Adult; Aeromonas; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Diarrhea; | 2017 |
Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Topics: Bangladesh; Cholera; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fe | 2015 |
Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in North India.
Topics: Anti-Bacterial Agents; Cholera; Cloxacillin; Disease Outbreaks; DNA Fingerprinting; Endopeptidases; | 2009 |
Drug sensitivity pattern of cholera in children.
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Cholera; Diarrhea; Humans; Microbial Sen | 2002 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Chole | 2005 |
Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment.
Topics: Animals; Bacterial Adhesion; Biofilms; Cholera; Disease Transmission, Infectious; Environment; Feces | 2006 |
Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child; Child, P | 1998 |
[Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
Topics: Animals; Anti-Infective Agents; Cholera; Drug Resistance, Microbial; Fluoroquinolones; Mice; Mutatio | 2000 |